Gary Petersmeyer - Cooper Companies Independent Director
COO Stock | USD 101.46 0.38 0.37% |
Director
Mr. Gary S. Petersmeyer is Independent Director of Cooper Companies Inc. Mr. Petersmeyer currently serves as a consultant to companies in the pharmaceutical and medical device industries. Most recently he cofounded Aesthetic Sciences Corporation in 2004 and served as the Chief Executive Officer and Chairman until December 2010. Prior to that he served as President and Chief Operating Officer of Pherin Pharmaceuticals, Inc. from 2000 to 2001 and as President and Chief Operating Officer of Collagen Corporationrationration, Inc. from 1995 to 1997 and as Chief Executive Officer from 1997 to 1999. From 1976 to 2000 he served in various management positions for pharmaceutical and medical device companies. Mr. Petersmeyer serves as a director and member of the compensation and audit committees of Omnicell, Inc. . He also served as director and chairman of the board of Cardica, Inc. through November 2015. He has previously served on the boards of Visx Incorporated and Roxro Pharmaceuticals prior to their acquisitions. He also serves as chairman of the board for Positive Coaching Alliance, a nonprofit organization dedicated to improving youth sports. since 2013.
Age | 73 |
Tenure | 11 years |
Address | 6101 Bollinger Canyon Road, San Ramon, CA, United States, 94583 |
Phone | 925 460 3600 |
Web | https://www.coopercos.com |
Gary Petersmeyer Latest Insider Activity
Tracking and analyzing the buying and selling activities of Gary Petersmeyer against Cooper Companies stock is an integral part of due diligence when investing in Cooper Companies. Gary Petersmeyer insider activity provides valuable insight into whether Cooper Companies is net buyers or sellers over its current business cycle. Note, Cooper Companies insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cooper Companies'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Gary Petersmeyer six days ago Acquisition by Gary Petersmeyer of 655 shares of Cooper Companies subject to Rule 16b-3 |
Cooper Companies Management Efficiency
The company has Return on Asset of 0.0269 % which means that on every $100 spent on assets, it made $0.0269 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0387 %, implying that it generated $0.0387 on every 100 dollars invested. Cooper Companies' management efficiency ratios could be used to measure how well Cooper Companies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of March 2024, Return On Capital Employed is likely to grow to 0.05. Also, Return On Assets is likely to grow to 0.03. As of the 29th of March 2024, Total Assets is likely to grow to about 14.1 B. Also, Non Current Assets Total is likely to grow to about 12 BSimilar Executives
Showing other executives | DIRECTOR Age | ||
Andrew Hunt | Warby Parker | N/A | |
Thomas Schreck | Ekso Bionics Holdings | 60 | |
Ann Cookson | Ekso Bionics Holdings | N/A | |
Paul Mieyal | Nephros | 45 | |
Marilyn Hamilton | Ekso Bionics Holdings | 64 | |
Ted Wang | Ekso Bionics Holdings | 50 | |
Malcom Persen | Nephros | 60 | |
Jack Peurach | Ekso Bionics Holdings | 48 | |
Amy Wendell | Ekso Bionics Holdings | 56 | |
Theodore Wang | Ekso Bionics Holdings | 51 | |
Alisa Lask | Nephros | N/A | |
Matthew Rosenberg | Nephros | 33 | |
Dan Boren | Ekso Bionics Holdings | 40 | |
Arthur Amron | Nephros | 61 | |
Thomas Gwydir | Nephros | N/A | |
Stanley Stern | Ekso Bionics Holdings | 60 | |
Alfred Vargas | Nephros | N/A | |
Howard Palefksy | Ekso Bionics Holdings | N/A | |
Oliver Spandow | Nephros | N/A | |
Moshe Pinto | Nephros | N/A | |
Charles Li | Ekso Bionics Holdings | N/A |
Management Performance
Return On Equity | 0.0387 | ||||
Return On Asset | 0.0269 |
Cooper Companies Leadership Team
Elected by the shareholders, the Cooper Companies' board of directors comprises two types of representatives: Cooper Companies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cooper. The board's role is to monitor Cooper Companies' management team and ensure that shareholders' interests are well served. Cooper Companies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cooper Companies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Weiss, CEO and President Non-Independent Director and Member of Science and Technology Committee | ||
Carol Kaufman, Chief Admin. Officer, Chief Governance Officer, Executive VP and Secretary | ||
Teresa Madden, Independent Director | ||
Holly Sheffield, Executive Vice President and Chief Strategy Officer | ||
Kim Duncan, Senior Director - Investor Relations | ||
Agostino Ricupati, Senior Vice President - Finance and Tax, Chief Accounting Officer | ||
Mark Drury, Vice President General Counsel, Secretary | ||
Gerard III, I CooperVision | ||
A Bender, Independent Chairman of the Board | ||
Daniel McBride, Chief Operating Officer, Executive Vice President, President of CooperVision, Inc. | ||
Thomas Bender, Independent Chairman of the Board | ||
Tina Maloney, Principal Accounting Officer and Corporate Controller | ||
Paul Remmell, President and CEO of CooperSurgical Inc. | ||
Maria Rivas, Independent Director | ||
Albert White, President, Chief Executive Officer, Director | ||
Juan Aragon, Pres Division | ||
Albert III, CEO President | ||
Allan Rubenstein, Independent Vice Chairman of the Board, Lead Director | ||
Donald Press, Independent Director | ||
Stanley Zinberg, Independent Director | ||
Steven Rosenberg, Independent Director | ||
William Kozy, Lead Independent Director | ||
Randal Golden, Vice President, General Counsel, Secretary | ||
Robert Auerbach, President - CooperSurgical | ||
Warner H, President CooperVision, Inc | ||
Gary Petersmeyer, Independent Director | ||
Gregory Matz, CFO, Chief Risk Officer and Sr. VP | ||
Daniel Esq, Executive COO | ||
Jody Lindell, Independent Director | ||
Colleen Jay, Independent Director | ||
Nicholas Khadder, General Secretary | ||
Michael Kalkstein, Independent Director | ||
Brian Andrews, Chief Financial Officer, Executive Vice President, Treasurer |
Cooper Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cooper Companies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0387 | ||||
Return On Asset | 0.0269 | ||||
Profit Margin | 0.08 % | ||||
Operating Margin | 0.16 % | ||||
Current Valuation | 22.89 B | ||||
Shares Outstanding | 198.76 M | ||||
Shares Owned By Insiders | 0.53 % | ||||
Shares Owned By Institutions | 99.47 % | ||||
Number Of Shares Shorted | 2.48 M | ||||
Price To Earning | 35.89 X |
Cooper Companies Investors Sentiment
The influence of Cooper Companies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cooper. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cooper Companies' public news can be used to forecast risks associated with an investment in Cooper. The trend in average sentiment can be used to explain how an investor holding Cooper can time the market purely based on public headlines and social activities around The Cooper Companies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cooper Companies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cooper Companies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cooper Companies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cooper Companies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cooper Companies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cooper Companies' short interest history, or implied volatility extrapolated from Cooper Companies options trading.
Pair Trading with Cooper Companies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cooper Companies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cooper Companies will appreciate offsetting losses from the drop in the long position's value.Moving together with Cooper Stock
0.62 | BSX | Boston Scientific Corp Financial Report 24th of April 2024 | PairCorr |
Moving against Cooper Stock
0.76 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.72 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.63 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
0.62 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
0.49 | PIIIW | P3 Health Partners | PairCorr |
The ability to find closely correlated positions to Cooper Companies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cooper Companies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cooper Companies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling The Cooper Companies to buy it.
The correlation of Cooper Companies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cooper Companies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cooper Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cooper Companies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in The Cooper Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Cooper Stock analysis
When running Cooper Companies' price analysis, check to measure Cooper Companies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cooper Companies is operating at the current time. Most of Cooper Companies' value examination focuses on studying past and present price action to predict the probability of Cooper Companies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cooper Companies' price. Additionally, you may evaluate how the addition of Cooper Companies to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Cooper Companies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cooper Companies. If investors know Cooper will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cooper Companies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 0.008 | Earnings Share 1.46 | Revenue Per Share 18.496 | Quarterly Revenue Growth 0.085 |
The market value of Cooper Companies is measured differently than its book value, which is the value of Cooper that is recorded on the company's balance sheet. Investors also form their own opinion of Cooper Companies' value that differs from its market value or its book value, called intrinsic value, which is Cooper Companies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cooper Companies' market value can be influenced by many factors that don't directly affect Cooper Companies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cooper Companies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cooper Companies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cooper Companies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.